Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control

被引:36
作者
Grassi, Mariana Lopes [1 ,2 ]
Palma, Camila de Souza [1 ,2 ]
Thome, Carolina Hassibe [1 ,2 ]
Lanfredi, Guilherme Pauperio [1 ,2 ]
Poersch, Aline [1 ]
Faca, Vitor Marcel [1 ,2 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Ribeirao Preto Blood Ctr, Cell Based Therapy Ctr, Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Epithelial to mesenchymal transition; Epidermal growth factor; Cell cycle; Ovarian cancer; RIBOSOMAL-PROTEINS; FACTOR RECEPTOR; STATISTICAL-MODEL; EXPRESSION; TRANSCRIPTION; GENE; INVOLVEMENT; PROGRESSION; MODULATION; MIGRATION;
D O I
10.1016/j.jprot.2016.06.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial to mesenchymal transition (EMT) is a well-orchestrated process that culminates with loss of epithelial phenotype and gain of a mesenchymal and migratory phenotype. EMT enhances cancer cell invasiveness and drug resistance, favoring metastasis. Dysregulation of transcription factors, signaling pathways, miRNAs and growth factors including EGF, TGF-beta and HGF can trigger EMT. In ovarian cancer, overexpression of the EGFR family is associated with more aggressive clinical behavior. Here, the ovarian adenocarcinoma cell line Caov-3 was induced to EMT with EGF in order to identify specific mechanisms controlled by this process. Caov-3 cells induced to EMT were thoroughly validated and a combination of subcellular proteome enrichment, GEL-LC-MS/MS and SILAC strategy allowed consistent proteome identification and quantitation. Protein network analysis of differentially expressed proteins highlighted regulation of metabolism and cell cycle. Activation of relevant signaling pathways, such as PI3K/Akt/mTOR and Ras/Erk MAPK, in response to EGF-induced EMT was validated. Also, EMT did not affected the proliferation rate of Caov-3 cells, but led to cell cycle arrest in G1 phase regulated by increased levels of p21Wafl/Cip1, independently of p53. Furthermore, a decrease in G1 and G2 checkpoint proteins was observed, supporting the involvement of EGF-induced EMT in cell cycle control. Biological significance: Cancer is a complex multistep process characterized by accumulation of several hallmarks including epithelial to mesenchymal transition (EMT), which promotes cellular and microenvironmental changes resulting in invasion and migration to distant sites, favoring metastasis. EMT can be triggered by different extracellular stimuli, including growth factors such as EGF. In ovarian cancer, the most lethal gynecological cancer, overexpression of the EGFR family is associated with more aggressive clinical behavior, increasing mortality rate caused by metastasis. Our proteomic data, together with specific validation of specific cellular mechanisms demonstrated that EGF-induced EMT in Caov-3 cells leads to important alterations in metabolic process (protein synthesis) and cell cycle control, supporting the implication of EGF/EMT in cancer metastasis, cancer stem cell generation and, therefore, poor prognosis for the disease. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 62 条
  • [1] Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis
    Adam, Rosalyn M.
    Yang, Wei
    Di Vizio, Dolores
    Mukhopadhyay, Nishit K.
    Steen, Hanno
    [J]. BMC CELL BIOLOGY, 2008, 9 (1)
  • [2] Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium
    Ahmed, N
    Maines-Bandiera, S
    Quinn, MA
    Unger, WG
    Dedhar, S
    Auersperg, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (06): : C1532 - C1542
  • [3] PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
    Avasarala, Sreedevi
    Van Scoyk, Michelle
    Rathinam, Manoj Kumar Karuppusamy
    Zerayesus, Sereke
    Zhao, Xiangmin
    Zhang, Wei
    Pergande, Melissa R.
    Borgia, Jeffrey A.
    DeGregori, James
    Port, J. David
    Winn, Robert A.
    Bikkavilli, Rama Kamesh
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (21) : 13479 - 13489
  • [4] Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
    Bali, A
    O'Brien, PM
    Edwards, LS
    Sutherland, RL
    Hacker, NF
    Henshall, SM
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5168 - 5177
  • [5] The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
    Bartlett, JMS
    Langdon, SP
    Simpson, BJB
    Stewart, M
    Katsaros, D
    Sismondi, P
    Love, S
    Scott, WN
    Williams, ARW
    Lessells, AM
    Macleod, KG
    Smyth, JF
    Miller, WR
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 301 - 306
  • [6] Regulation of cancer cell metabolism
    Cairns, Rob A.
    Harris, Isaac S.
    Mak, Tak W.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (02) : 85 - 95
  • [7] Direct Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining
    Cook, Rebecca
    Zoumpoulidou, Georgia
    Luczynski, Maciej T.
    Rieger, Simone
    Moquet, Jayne
    Spanswick, Victoria J.
    Hartley, John A.
    Rothkamm, Kai
    Huang, Paul H.
    Mittnacht, Sibylle
    [J]. CELL REPORTS, 2015, 10 (12): : 2006 - 2018
  • [8] Epithelial mesenchymal transition in ovarian carcinoma
    Davidson, Ben
    Trope, Claes G.
    Reich, Reuven
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [9] Evaluating cell lines as tumour models by comparison of genomic profiles
    Domcke, Silvia
    Sinha, Rileen
    Levine, Douglas A.
    Sander, Chris
    Schultz, Nikolaus
    [J]. NATURE COMMUNICATIONS, 2013, 4
  • [10] Snail, slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
    Elloul, S
    Elstrand, MB
    Nesland, JM
    Tropé, CG
    Kvalheim, G
    Goldberg, I
    Reich, R
    Davidson, B
    [J]. CANCER, 2005, 103 (08) : 1631 - 1643